Alexion Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
ALXN Alexion Pharmaceuticals Inc
MSFT Microsoft Corp
PENN Penn National Gaming Inc
ABEV Ambev SA
AEG Aegon NV
PFE Pfizer Inc
CRON Cronos Group Inc
CVSI CV Sciences Inc
OSB Norbord Inc
QCOM Qualcomm Inc
Go

Health Care : Biotechnology | Large Cap GrowthCompany profile

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic products. The Company's products include Soliris (eculizumab), Strensiq (asfotase alfa) and Kanuma (sebelipase alfa). The Company's clinical development programs include Soliris (eculizumab), cPMP (ALXN1101), SBC-103, ALXN1210 (IV) and ALXN1210 (Subcutaneous). Its Soliris is the therapeutic approved for patients with either paroxysmal nocturnal hemoglobinuria (PNH) or hemolytic uremic syndrome (aHUS). PNH and aHUS result from chronic uncontrolled activation of the complement component of the immune system. Its Strensiq is for the treatment of patients with Hypophosphatasia (HPP). Its product, Kanuma is for the treatment of patients with Lysosomal Acid Lipase Deficiency (LAL-D). It is a recombinant form of the human LAL enzyme, which is a replacement therapy that is approved for the treatment for patients with LAL-D.

Price
Delayed
$111.68
Day's Change
-0.05 (-0.04%)
Bid
--
Ask
--
B/A Size
--
Day's High
113.99
Day's Low
110.81
Volume
(Average)

Today's volume of 1,156,469 shares is on pace to be in-line with ALXN's 10-day average volume of 1,874,799 shares.

1,156,469
  • Prev Close
    111.73
  • Today's Open
    111.89
  • Day's Range
    110.81-113.99
  • Avg Vol (10-day)
    1.9M
  • Last (time)
    2:00p ET 01/16/19
  • Last (size)
    100
  • 52-Wk Range
    92.56 - 140.77
    LowHigh
  • (09/28/18 - 12/24/18)
    20.66%
  • 39.2%
  • Market Cap
    24.9B
  • Shares Outstanding
    223.1M
  • 1.11
  • 100.71x
  • No dividend
  • Ex-dividend
    No dividend
  • 1.4
  • 95.60
  • (% of float 12/31/18)
    1.67

Latest News

January 15, 2019
7:11 am ET
MarketWatch
January 11, 2019
4:43 pm ET
MarketWatch
January 10, 2019
8:01 am ET
MarketWatch
January 07, 2019
7:30 am ET
BusinessWire
January 04, 2019
7:22 am ET
MarketWatch
January 02, 2019
4:30 pm ET
BusinessWire
December 21, 2018
4:30 pm ET
BusinessWire
11:23 am ET
BusinessWire
December 16, 2018
10:37 am ET
MarketWatch
December 03, 2018
2:32 pm ET
BusinessWire
November 20, 2018
4:30 pm ET
BusinessWire
November 14, 2018
7:13 am ET
BusinessWire
November 10, 2018
9:54 am ET
MarketWatch
November 07, 2018
4:30 pm ET
BusinessWire
November 02, 2018
11:05 am ET
BusinessWire
8:15 am ET
Globe Newswire
November 01, 2018
10:23 am ET
BusinessWire
October 24, 2018
7:49 am ET
MarketWatch
6:35 am ET
BusinessWire
6:30 am ET
BusinessWire
September 26, 2018
6:51 am ET
MarketWatch
6:45 am ET
MarketWatch
September 05, 2018
7:40 am ET
MarketWatch
August 14, 2018
7:46 am ET
MarketWatch
August 07, 2018
7:54 am ET
MarketWatch
7:42 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.